EIF4A3 and cancer: These results suggested that the 73HOXC-AS1 overexpression plasmid-activated Wntβ-catenin classic signaling pathway and eIF4AIII expression increased by LV-eIF4AIII-RNAi (44682-1) had similar effects on cancer cells, while the combined adoption of the two would better improve the invasion ability of cells [25].